The Dose Effects of Isomaltulose and Sucrose on Glycaemic and Insulinemic Response

NCT04653207 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2021-12-23

No results posted yet for this study

Summary

This study will determine the glycaemic and insulinaemic response and sensory profile of the drinks with various ratios sucrose:isomaltulose. The information will be useful for manufacturers of beverages to produce blood glucose friendlier drinks. The information will also be useful for dieticians and clinicians in recommending foods and drinks for people with diabetes. The information will also be useful to the public for making better food choices. The data will also provide insights on how the different ratios of sweeteners may affect glycaemic and insulinaemic indices (GI and II).

Conditions

Interventions

OTHER

Glucose Solution 1

50g glucose dissolve in 300ml of water

OTHER

Glucose Solution 2

50g glucose dissolve in 300ml of water

OTHER

Glucose Solution 3

50g glucose dissolve in 300ml of water

OTHER

Sucrose/Isomaltulose 100:0

50g sucrose dissolve in 300ml of water

OTHER

Sucrose/Isomaltulose 0:100

50g isomaltulose dissolve in 300ml of water

OTHER

Sucrose/Isomaltulose 50:50

25g sucrose and 25g isomaltulose dissolve in 300ml of water

OTHER

Sucrose/Isomaltulose 60:40

30g sucrose and 20g isomaltulose dissolve in 300ml of water

OTHER

Sucrose/Isomaltulose 70:30

35g sucrose and 15g isomaltulose dissolve in 300ml of water

OTHER

Sucrose/Isomaltulose 80:20

40g sucrose and 10g isomaltulose dissolve in 300ml of water

Sponsors & Collaborators

  • Singapore Institute of Food and Biotechnology Innovation

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2020-10-28
Completion
2020-10-28

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04653207 on ClinicalTrials.gov